Business Description

Sonic Healthcare Ltd
NAICS : 621511
SIC : 8071
ISIN : AU000000SHL7
Share Class Description:
ASX:SHL: Ordinary SharesDescription
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the US, and 35% in Europe.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.11 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.59 | |||||
Debt-to-EBITDA | 2.74 | |||||
Interest Coverage | 5.32 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.31 | |||||
Beneish M-Score | -2.43 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.1 | |||||
3-Year EBITDA Growth Rate | -13.2 | |||||
3-Year EPS without NRI Growth Rate | -26.8 | |||||
3-Year FCF Growth Rate | -33.4 | |||||
3-Year Book Growth Rate | 7.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 11.94 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.31 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 31.61 | |||||
9-Day RSI | 37.54 | |||||
14-Day RSI | 41.1 | |||||
3-1 Month Momentum % | -0.07 | |||||
6-1 Month Momentum % | 3.14 | |||||
12-1 Month Momentum % | -4.36 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.03 | |||||
Quick Ratio | 0.92 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 52.91 | |||||
Days Sales Outstanding | 49.01 | |||||
Days Payable | 267.15 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.86 | |||||
Dividend Payout Ratio | 0.93 | |||||
3-Year Dividend Growth Rate | 6.5 | |||||
Forward Dividend Yield % | 3.9 | |||||
5-Year Yield-on-Cost % | 5.04 | |||||
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | -4.93 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 83.73 | |||||
Operating Margin % | 9.86 | |||||
Net Margin % | 5.85 | |||||
FCF Margin % | 7.67 | |||||
ROE % | 6.87 | |||||
ROA % | 3.72 | |||||
ROIC % | 5.06 | |||||
3-Year ROIIC % | -27.09 | |||||
ROC (Joel Greenblatt) % | 30.75 | |||||
ROCE % | 7.67 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 24.12 | |||||
Forward PE Ratio | 21.26 | |||||
PE Ratio without NRI | 24.12 | |||||
Shiller PE Ratio | 16.07 | |||||
Price-to-Owner-Earnings | 13.11 | |||||
PEG Ratio | 3.17 | |||||
PS Ratio | 1.41 | |||||
PB Ratio | 1.61 | |||||
Price-to-Free-Cash-Flow | 18.36 | |||||
Price-to-Operating-Cash-Flow | 10.6 | |||||
EV-to-EBIT | 18.47 | |||||
EV-to-Forward-EBIT | 18.96 | |||||
EV-to-EBITDA | 10.05 | |||||
EV-to-Forward-EBITDA | 10.11 | |||||
EV-to-Revenue | 1.88 | |||||
EV-to-Forward-Revenue | 1.84 | |||||
EV-to-FCF | 24.56 | |||||
Price-to-GF-Value | 0.77 | |||||
Price-to-Projected-FCF | 0.71 | |||||
Price-to-DCF (Earnings Based) | 1.81 | |||||
Price-to-DCF (FCF Based) | 0.87 | |||||
Price-to-Median-PS-Value | 0.76 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.39 | |||||
Earnings Yield (Greenblatt) % | 5.41 | |||||
FCF Yield % | 5.43 | |||||
Forward Rate of Return (Yacktman) % | 15.81 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sonic Healthcare Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 9,330.279 | ||
EPS (TTM) (A$) | 1.138 | ||
Beta | 0.91 | ||
3-Year Sharpe Ratio | -0.58 | ||
3-Year Sortino Ratio | -0.71 | ||
Volatility % | 20.12 | ||
14-Day RSI | 41.1 | ||
14-Day ATR (A$) | 0.570965 | ||
20-Day SMA (A$) | 28.321 | ||
12-1 Month Momentum % | -4.36 | ||
52-Week Range (A$) | 23.58 - 29.61 | ||
Shares Outstanding (Mil) | 480.4 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sonic Healthcare Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sonic Healthcare Ltd Stock Events
Event | Date | Price (A$) | ||
---|---|---|---|---|
No Event Data |
Sonic Healthcare Ltd Frequently Asked Questions
What is Sonic Healthcare Ltd(ASX:SHL)'s stock price today?
The current price of ASX:SHL is A$27.45. The 52 week high of ASX:SHL is A$29.61 and 52 week low is A$23.58.
When is next earnings date of Sonic Healthcare Ltd(ASX:SHL)?
The next earnings date of Sonic Healthcare Ltd(ASX:SHL) is 2025-08-21.
Does Sonic Healthcare Ltd(ASX:SHL) pay dividends? If so, how much?
The Dividend Yield %  of Sonic Healthcare Ltd(ASX:SHL) is 3.86% (As of Today), Highest Dividend Payout Ratio of Sonic Healthcare Ltd(ASX:SHL) was 0.98. The lowest was 0.31. And the median was 0.7. The  Forward Dividend Yield % of Sonic Healthcare Ltd(ASX:SHL) is 3.9%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |